GNOM Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Also see: GNOM Shares Outstanding History and GNOM YTD Return |
GNOM Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Also see: GNOM Shares Outstanding History and GNOM YTD Return |
GNOM Market Cap History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
+130.20% CAGR Mouse over chart for data details
|
GNOM Stock Price Chart |
About Complete Genomics Inc |
Complete Genomics is a life sciences company that has developed and commercialized a deoxyribonucleic acid sequencing platform for whole human genome sequencing and analysis. Co.'s Complete Genomics Analysis Platform Platform, combines its human genome sequencing technology with its informatics and data management software and its outsourced service model to provide its customers with data that is ready to be used for genome-based research. Co. sells its whole human genome sequencing service through its direct field sales and support organizations. We show 116 historical shares outstanding datapoints in our GNOM shares outstanding history coverage, used to compute GNOM market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing GNOM market cap history over the course of time is important for investors interested in comparing GNOM's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of GNOM versus a peer is one thing; comparing GNOM market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like GNOM can fluctuate over the course of history. With this page we aim to empower investors researching GNOM by allowing them to research the GNOM market cap history. |
GNOM Current Stock Quote |
Free GNOM Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |
Video: The Importance of Market Cap | |
|
GNOM Share Performance |
Market Cap Peers |
Global X Genomics and amp; Biotechnology Etf (GNOM) is categorized under the Miscellaneous sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
GNPK Market Cap History |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.